Status:
COMPLETED
Pain Monitoring After Breast Biopsy: Benefit of E-health
Lead Sponsor:
Institut du Cancer de Montpellier - Val d'Aurelle
Conditions:
Breast Cancer
Biopsy Wound
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Each year, approximately 1500 breast biopsies (1000 microbiopsies and 500 macrobiopsies) are performed in the radiologic department of the Montpellier Cancer Institute (ICM). This exam, which is relat...
Detailed Description
The primary objective is to compare the benefit of intervention by e-health (phone consultation with a professional or connected objects (smartphone or tablet)) with the standard follow up of the pain...
Eligibility Criteria
Inclusion
- Patient with diagnostic breast biopsy at ICM
- Age \> 18 years
- Informed patient and signed informed consent received
- Affiliation to a social security system
Exclusion
- Patient without phone number
- Patient with previous biopsy in 6 months prior to study
- Pregnant and breastfeeding woman
- Patient whose regular follow-up is initially impossible for psychological, family, social or geographical reasons
- Patient under legal protection (guardianship, curatorship or safeguarding of justice)
Key Trial Info
Start Date :
February 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 19 2024
Estimated Enrollment :
193 Patients enrolled
Trial Details
Trial ID
NCT04456920
Start Date
February 9 2021
End Date
April 19 2024
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icm Val D'Aurelle
Montpellier, Hérault, France, 34298